In a model of brain ischemia/reperfusion damage was found that resistin administration prior to the stroke induction, reduced infarct size and improved outcome, reducing cleaved levels of PARP-1 used as a marker of cellular apoptosis [43]. This evidence concerns the gene RETN and Stroke.